[Neoadjuvant immunotherapy ushers in a new era of gastric cancer treatment].
Zhonghua Wei Chang Wai Ke Za Zhi
; 27(7): 653-658, 2024 Jul 25.
Article
in Zh
| MEDLINE
| ID: mdl-39004979
ABSTRACT
Recent advances in tumor immunology have made immunotherapy a new direction for neoadjuvant treatment of gastric cancer. Multiple clinical trials have confirmed that combining immunotherapy with chemotherapy and targeted therapy in the neoadjuvant treatment of gastric cancer can effectively improve treatment response and prolong patient survival time. This article aims to comment on the application of immunotherapy in the neoadjuvant treatment of gastric cancer, exploring its mechanisms, integration strategies with traditional treatments, safety, and personalized precision therapy in the hope of providing new insights and directions for the field of gastric cancer treatment.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Neoadjuvant Therapy
/
Immunotherapy
Limits:
Humans
Language:
Zh
Journal:
Zhonghua Wei Chang Wai Ke Za Zhi
Journal subject:
GASTROENTEROLOGIA
Year:
2024
Document type:
Article
Affiliation country:
China